Covid-19 Moskitofree box approved by the Institut Pasteur, effective or not?

Published by Elodie D., Cécile D. · Published on 11 January 2021 at 15h46 · Updated on 11 January 2021 at 16h51
Company Moskitofree has developed anti-covid boxes and necklaces with the Aeriashield technology said to erase up to 99% of coronaviruses in the air. The Lille Institut Pasteur has tested and validated Aeriashield, but remains cautious with such a system. How does this box work?

The Moskitofree company usually provides anti-mosquito products. Yet, their latest creation has a greater reach. Aeriashield is a box said to improve the air quality we breathe in indoors, a box with antiviral and antibacterial properties. This system has been tested in laboratory by the Lille Institut Pasteur and delivers encouraging results – although the laboratory urges us not to claim victory too early.

Aeriashield is a system created to kill airborne viruses in closed places like homes and offices. This system emits and electric shock all around the body of the person wearing it, covering two square meters around them, and is said to be enable to make particles drop onto the floor. They have also added ozone to come and "tackles the virus".

This process has been tested by the service of Doctor Michèle Vialette, head of the Microbiological Security Unit and head of the High Security Laboratory at the Lille Institut Pasteur.

After spreading coronavirus in an airtight bedroom, in only ten minutes, 93.5% of human coronaviruses have been erased from the air thanks to the necklace box, sold for 79 euros with a 24-hour autonomy. 99% of the coronaviruses were eliminated in 5 minutes thanks to the Travel box, sold for 89 euros with a 7-hour autonomy. The only flaw, Doctor Vialette’s team has been carrying out searchers on the HCoV-229E, a human coronavirus used as a model virus. This virus is different from the SARS-CoV-2, the virus originating Covid-19, but both of them are part of the same coronavirus family. Aeriashield has then been tested on the HCov-229E in laboratory.

Results remain very very positive and encouraging: we can thus hope this technology will be developed and adapted to the SARS-CoV-2 in the upcoming months or years.

Practical information

Refine your search
Refine your search
Refine your search
Refine your search